Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M61,961Revenue (TTM) $M11,449Net Margin (%)32.3Altman Z-Score5.9
Enterprise Value $M63,572EPS (TTM) $16.9Operating Margin %45.0Piotroski F-Score5
P/E(ttm)16.9Beneish M-Score-2.5Pre-tax Margin (%)43.1Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %24.8Quick Ratio2.3Cash flow > EarningsY
Price/Sales5.55-y EBITDA Growth Rate %28.9Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow16.6y-y EBITDA Growth Rate %13.6ROA % (ttm)17.4Higher Current Ratio y-yN
Dividend Yield %--PEG0.6ROE % (ttm)33.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M216ROIC % (ttm)28.4Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BIIB is held by these investors:



BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PANGIA ROBERT WDirector 2017-01-09Sell5,450$295.39-2.18view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-12-01Sell48$296.53-2.56view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-04Sell262$311.94-7.37view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-03Sell380$313-7.69view
DORSA CAROLINEDirector 2016-09-22Sell27,570$314-7.98view
SCANGOS GEORGE ACEO 2016-07-21Sell157$2803.19view
Koppel AdamEVP, Strategy and Bus. Dev. 2016-06-06Sell555$290-0.37view
SCANGOS GEORGE ACEO 2016-06-03Sell842$290-0.37view
SCANGOS GEORGE ACEO 2016-06-01Sell3,855$289.74-0.28view
SCANGOS GEORGE ACEO 2016-05-25Sell157$2803.19view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
GuruFocus Interview: Orbimed Guru Sam Isaly on Investing in New Era of Healthcare Feb 15 2017 
8 Stocks Trading Below Peter Lynch Value Jan 23 2017 
7 Stocks for 2017 Jan 20 2017 
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
John Paulson Continues to Buy These 8 Stocks Dec 23 2016 
Health Care Companies Showing Good Defensive Potential Dec 22 2016 
John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
Paul Tudor Jones Exits EMC, Boosts Facebook, PepsiCo, Biogen Nov 23 2016 
Jeff Auxier Expands Holdings in Chemical and Biotech Companies Nov 21 2016 

More From Other Websites
Celgene MS Drug Reports Positive Phase 3 Data Feb 20 2017
This Keeps Driving Sanofi’s Growth Feb 20 2017
Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment Feb 20 2017
​Shkreli defends drug prices, spars with protesters at heated UMass Boston event Feb 16 2017
Tesaro sees a $5B market opportunity for its cancer drug Feb 16 2017
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback Feb 16 2017
Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference Feb 15 2017
Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next? Feb 15 2017
Merck Halts Late-Stage Alzheimer’s Drug Trial Feb 15 2017
Bioverativ's hemophilia hopes Feb 15 2017
Regeneron: It's All Riding On Dupixent Feb 13 2017
Biogen’s Spinraza Faces Insurance Coverage Hurdles Feb 13 2017
Biotech ETFs Powered by Q4 Earnings Feb 10 2017
Humana to limit coverage of pricy Biogen drug Feb 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)